$AH News
Last published 12y ago
- 12y agoASDNHGSIHLSVG+26Pershing Square Proposes Independent Slate For Allergan Board of DirectorsBusiness WireNEW YORK--(BUSINESS WIRE)--Pershing Square Capital Management, L.P. (“Pershing Square”) today announced a slate of six highly experienced, independent directors for the board of directors of Allergan, Inc. (“Allergan”). The six members of the slate are: Betsy Atkins, Cathleen P. Black, Fredric N. Eshelman, Steven J. Shulman, David A. Wilson and John J. Zillmer.
- 12y agoAHAccretive Health Provides Restatement UpdateBusiness WireCHICAGO--(BUSINESS WIRE)--Accretive Health, Inc. (NYSE:AH) today announced that following discussions with its independent auditors, the Company has determined that although its work associated with its financial restatement is substantially complete, it has taken longer than anticipated and more time is needed. As a result, the Company will not be in a position to complete its financial restateme ...
- 12y agoAHPatrick Funck Joins Accretive Health as Chief Information OfficerBusiness WireCHICAGO--(BUSINESS WIRE)--Accretive Health, Inc. (NYSE: AH) has announced the appointment of Patrick Funck as senior vice president and chief information officer. In this role, Mr. Funck will accelerate the investment that Accretive Health is making in innovative technology solutions that deliver on patient engagement strategies and enable future growth for the organization.
- 12y agoAHAccretive Health Continues Company RestructuringBusiness WireCHICAGO--(BUSINESS WIRE)--Accretive Health, Inc. (NYSE: AH), today announced the continuation of a corporate restructuring plan originated last year. This plan is designed to allow the company to more effectively and efficiently allocate necessary resources for innovation, growth and enhanced client service. Specific changes include optimizing Accretive Health’s current geographic footprint by tra ...
- 13y agoAHAccretive Health Appoints Two New Board Members and Authorizes $50 Million Share Repurchase ProgramBusiness WireCHICAGO--(BUSINESS WIRE)--Accretive Health, Inc. (NYSE: AH), today announced the appointment of two new independent directors to its Board of Directors. Robert Stanek, former president and CEO of Catholic Health East, and Alex Mandl, non-executive chairman of Gemalto and former President, COO and CFO at AT&T, joined the Board effective November 11, 2013.
- 13y agoAHAccretive Health Provides Business and Restatement UpdateBusiness WireCHICAGO--(BUSINESS WIRE)--Accretive Health, Inc. (NYSE: AH), today provided an update on the status of its ongoing restatement of financial results and the current state of the company’s business.
- 13y agoAHAccretive Health to Provide Business and Restatement Update on Nov. 13Business WireCHICAGO--(BUSINESS WIRE)--Accretive Health, Inc. (NYSE: AH) plans to provide a business update and an update on the status of the restatement of the company’s financial statements after the market closes on November 13, 2013, and will host a call on the same day at 4:00 p.m. CST (5:00 p.m. EST) to discuss the update.
- 13y agoAHAccretive Health Provides Compliance Solutions in Light of New RegulationsBusiness WireCHICAGO--(BUSINESS WIRE)--As new healthcare regulations are introduced across the country, Accretive Health (NYSE: AH) is offering a newly developed, integrated suite of solutions that serve to prepare its healthcare clients in this new environment. Specifically, Accretive Physician Advisory Services (AccretivePAS®) responded to the Centers for Medicare and Medicaid Services’ (CMS) release of the ...
- 13y agoAHAccretive Health Obtains New York Stock Exchange Listing ExtensionBusiness WireCHICAGO--(BUSINESS WIRE)--Accretive Health, Inc. (NYSE: AH) today announced that it has received an extension for continued listing and trading of the Company’s common stock on the New York Stock Exchange (“NYSE”).
- 13y agoAHAccretive Health Names Sean F. Orr as Chief Financial Officer and TreasurerBusiness WireCHICAGO--(BUSINESS WIRE)--Accretive Health, Inc. (NYSE:AH) announced today the appointment of Sean F. Orr as its new chief financial officer and treasurer. John Staton, who has served in those positions since 2005, has taken the position of senior vice president, provider business solutions, with the company.
- 13y agoAHAccretive Health Reports Inducement Grant under NYSE Rule 303A.08Business WireCHICAGO--(BUSINESS WIRE)--Accretive Health, Inc. (NYSE: AH) today announced that in connection with the appointment of Joseph G. Flanagan as Chief Operating Officer as of June 3, 2013, the company, under the New York Stock Exchange inducement grant exception, granted to Mr. Flanagan on June 3, 2013: (i) a nonstatutory stock option to purchase up to 800,000 shares of the company’s common stock at a ...
- 13y agoAHJoseph Flanagan Joins Accretive Health as Chief Operating OfficerBusiness WireCHICAGO--(BUSINESS WIRE)--Accretive Health, Inc. (NYSE: AH) announced today the appointment of Joseph Flanagan as its new chief operating officer. In this role, Mr. Flanagan will report to president and chief executive officer Stephen Schuckenbrock and be responsible for delivering exceptional operational discipline and client value creation throughout the company’s operations.
- 13y agoAHAccretive Health Reports Inducement Grant under NYSE Rule 303A.08Business WireCHICAGO--(BUSINESS WIRE)--Accretive Health, Inc. (NYSE: AH) today announced that pursuant to an employment agreement entered into with Richard Kimball Jr., on April 30, 2013, the company granted to Mr. Kimball on April 30, 2013 a non-qualified stock option under the New York Stock Exchange inducement grant exception. The inducement grant was approved by the company’s Board of Directors on April 23 ...
- 13y agoAHATTENTION SHAREHOLDERS: Accretive Healthcare, Inc (AH) Under Investigation by The Young Law Firm For Possible Violations of Federal Securities LawsBusiness WirePHOENIXVILLE, Pa.--(BUSINESS WIRE)--The Young Law Firm is investigating potential claims on behalf of investors in Accretive Healthcare, Inc (“Accretive Healthcare” or the “Company”) concerning possible violations of federal securities laws. The investigation concerns when the Company recognized revenue.
- 13y agoAHAccretive Health Reports Inducement Grant under NYSE Rule 303A.08Business WireCHICAGO--(BUSINESS WIRE)--Accretive Health, Inc. (NYSE: AH) today announced that pursuant to the employment agreement entered into with Stephen Schuckenbrock on April 2, 2013, the company granted to Mr. Schuckenbrock on April 3, 2013 a non-qualified stock option under the New York Stock Exchange inducement grant exception. The inducement grant was approved by the company’s Board of Directors on Ap ...
- 13y agoAHAccretive Health Names Stephen Schuckenbrock President and CEO; Mary Tolan Elected ChairmanBusiness WireCHICAGO--(BUSINESS WIRE)--The Board of Directors of Accretive Health, Inc. (NYSE: AH) announced today that Stephen Schuckenbrock, formerly president of Dell Services, has been named President and Chief Executive Officer and a member of the Accretive Board of Directors effective on April 3, 2013. Firm co-founder and current President and Chief Executive Officer Mary Tolan has been elected Chairman ...
- 13y agoAHLaw Offices of Todd M. Garber Announces Investigation of Accretive Health, Inc.Business WireLOS ANGELES--(BUSINESS WIRE)--The Law Offices of Todd M. Garber announces that it is investigating potential claims against Accretive Health, Inc. (“Accretive” or the “Company”) (NYSE:AH) concerning possible violations of federal securities laws. Accretive provides revenue cycle management services for hospitals and healthcare providers in the United States.
- 13y agoAHAccretive Health Provides Update Regarding Delayed Filing of Form 10-KBusiness WireCHICAGO--(BUSINESS WIRE)--Accretive Health, Inc. (the “Company”) previously indicated in its Form 12b-25 filed with the Securities and Exchange Commission (the “Commission”) on March 4, 2013 that the Company expected to receive a letter from the New York Stock Exchange (“NYSE”) indicating that the Company is not in compliance with the continued listing requirements under the timely filing criteria ...
- 13y agoAHAccretive Health Achieves Industry-Leading HITRUST Certification for Data Security and Protection of Private Patient Health InformationBusiness WireCHICAGO--(BUSINESS WIRE)--Accretive Health, Inc. (NYSE: AH) announced today that it has achieved from the Health Information Trust Alliance (HITRUST) Common Security Framework (CSF) Certified status. This status assures that Accretive Health is meeting the health care industry’s highest standards in managing risk and protecting health information. Achieving HITRUST CSF Certified status from HITRUS ...
- 13y agoAHSalem Health Selects Accretive Health for End-to-End Revenue Cycle ImprovementBusiness WireSALEM, Ore. & CHICAGO--(BUSINESS WIRE)--Salem Health, in Oregon’s mid-Willamette Valley, and Accretive Health, Inc. (NYSE: AH) today announced a multi-year strategic relationship to improve revenue cycle operations at Salem Health. This relationship will enable Salem Health to leverage Accretive Health’s distinctive operating model, including its rigorous processes and proprietary technology, to i ...
- 13y agoAHGlancy Binkow & Goldberg LLP Announces Investigation of Accretive Health, Inc.Business WireLOS ANGELES--(BUSINESS WIRE)--Glancy Binkow & Goldberg LLP announces that it is investigating potential claims on behalf of purchasers of the securities of Accretive Health, Inc. (“Accretive” or the “Company”) (NYSE:AH) concerning possible violations of federal securities laws. The investigation focuses on allegations that certain statements issued by Accretive between May 9, 2012 and February 26, ...
- 13y agoAHHolzer Holzer & Fistel, LLC Announces Investigation into Accretive Health, Inc.Business WireATLANTA--(BUSINESS WIRE)--Holzer Holzer & Fistel, LLC is investigating whether Accretive Health, Inc. (“Accretive” or the “Company”) (NYSE: AH) and/or certain of its officers complied with the federal securities laws when making statements to investors between May 9, 2012 and February 26, 2013. Specifically, the investigation focuses on a series of statements made during that time regarding Accret ...
- 13y agoAHAccretive Health Postpones Fourth Quarter and Full Year 2012 Earnings ReleaseBusiness WireCHICAGO--(BUSINESS WIRE)--Accretive Health, Inc. (NYSE: AH), a leading provider of revenue cycle and quality of care services to healthcare providers, today announced that it will postpone the release of its financial results for the fourth quarter and full year 2012, as well as its previously announced investor conference call scheduled for February 27, 2013, because it is evaluating the timing o ...
- 13y agoAHAccretive Health to Present at the 33rd Annual Cowen and Company Healthcare ConferenceBusiness WireCHICAGO--(BUSINESS WIRE)--Accretive Health, Inc. (NYSE: AH) today announced its management team will present the Company’s operations and business outlook at the 33rd Annual Cowen and Company Healthcare Conference on Tuesday, March 5thth 2013 at 9:20 am EDT in Boston.
- 13y agoAHAccretive Health to Release Fourth Quarter and Year-End 2012 Results on February 27Business WireCHICAGO--(BUSINESS WIRE)--Accretive Health, Inc. (NYSE: AH) announced today that it plans to release fourth quarter and year-end 2012 results before the market opens on Wednesday, February 27, 2013, and will host a conference call on the same day at 7:30 a.m. CST (8:30 a.m. EST) to discuss its financial results and business outlook for 2013.
- 13y agoAHAccretive Health to Present at the 31st Annual J.P. Morgan Healthcare ConferenceBusiness WireCHICAGO--(BUSINESS WIRE)--Accretive Health, Inc. (NYSE: AH) announced today that its management team will present the company's operations and business outlook at the 31st Annual J.P. Morgan Healthcare Conference on Tuesday, January 8th 2013 at 8:00 am PST in San Francisco.
- 13y agoAHAccretive Health to Host Investor Day December 3, 2012Business WireCHICAGO--(BUSINESS WIRE)--Accretive Health, Inc., (NYSE: AH), a healthcare technology and services company today announced details regarding its Investor Day.
- 14y agoAHAccretive Health Reports Third Quarter 2012 Financial ResultsBusiness WireCHICAGO--(BUSINESS WIRE)--Accretive Health, Inc. (NYSE: AH), today reported financial results for the quarter ended September 30, 2012.
- 14y agoAHAccretive Health Launches Innovative New Product Offering Focused on Improved Quality and Efficiency within Hospital Stays and Signs Inaugural ClientBusiness WireCHICAGO--(BUSINESS WIRE)--Accretive Health, Inc. (NYSE:AH), a healthcare technology and services company, today announced the launch of their Intra-Stay Quality (ISQ) Offering developed to enable U.S. healthcare providers to transition to a value based payment system focused on enhancing the patient experience in the acute care setting and the level of quality care delivered with improved efficien ...
- 14y agoAHAccretive Health, Inc. Announces Participation in Credit Suisse’s 2012 Health Care Investor ConferenceBusiness WireCHICAGO--(BUSINESS WIRE)--Accretive Health, Inc. (NYSE: AH), a leading provider of services to healthcare providers announced today that it will participate in the Credit Suisse’s 2012 Health Care Investor Conference in Phoenix. Ms. Mary Tolan, Co-Founder and Chief Executive Officer, and Mr. John Staton, Chief Financial Officer, will discuss the Company’s operations and business outlook starting a ...
- 14y agoAHAccretive Health Announces Third Quarter 2012 Financial Results Conference CallBusiness WireCHICAGO--(BUSINESS WIRE)--Accretive Health, Inc. (NYSE: AH) (the “Company”), a leading provider of services to healthcare providers announced that the Company will hold a conference call for investors on Wednesday, November 7, 2012, at 7:30 am central time. During the conference call, management will review highlights from the Company’s third quarter and year to date 2012 results, which will be an ...
- 14y agoAHAccretive Health Announces Share Buyback PlanBusiness WireCHICAGO--(BUSINESS WIRE)--Accretive Health, Inc. (NYSE:AH) today announced its Board of Directors has authorized the repurchase of up to $50 Million of the company’s common stock from time to time in the open market, or in privately negotiated transactions.
- 14y agoAHAccretive Health and Cancer Clinics of Excellence to Develop Innovative Program Providing Oncology Care ManagementBusiness WireCHICAGO & GREENWOOD VILLAGE, Colo.--(BUSINESS WIRE)--Accretive Health, Inc. (NYSE:AH), a healthcare technology and services company, and Cancer Clinics of Excellence (CCE), a national network of practice-owned, physician-driven community-based oncology practices, announced today that they have partnered to develop a novel, end-to-end oncology care management offering designed to enable healthcare ...
- 14y agoAHThe Shuman Law Firm Investigates Accretive Health, Inc.Business WireBOULDER, Colo.--(BUSINESS WIRE)--The Shuman Law Firm today announced that it is investigating potential claims against certain officers and directors of Accretive Health, Inc. (“Accretive Health” or the “Company”) (NYSE: AH). Accretive Health provides various services to healthcare providers including revenue cycle management; quality and total cost of care; and physician advisory services.
- 14y agoAHAccretive Health Reports Second Quarter 2012 Financial ResultsBusiness WireCHICAGO--(BUSINESS WIRE)--Accretive Health, Inc. (NYSE: AH), today reported financial results for the second quarter ended June 30, 2012.
- 14y agoAHAccretive Health Enters into Settlement Agreement with Minnesota State Attorney General with No Admission of Liability or WrongdoingBusiness WireCHICAGO--(BUSINESS WIRE)--Accretive Health, Inc. (NYSE: AH) today announced that it has entered into an agreement to settle the allegations brought against the Company by the Minnesota State Attorney General earlier this year following the theft of a laptop, from which no patient data was accessed. The settlement contains no admission of liability or wrongdoing.
- 14y agoAHAccretive Health Announces Second Quarter 2012 Financial Results Conference CallBusiness WireCHICAGO--(BUSINESS WIRE)--Accretive Health, Inc. (NYSE: AH) (the “Company”), a leading provider of services to healthcare providers announced that the Company will hold a conference call for investors on Wednesday, August 8, 2012, at 7:30 am central time. During the conference call, management will review highlights from the Company’s second quarter and year to date 2012 results, which will be ann ...
- 14y agoAHGoldman Scarlato Karon & Penny, P.C. Announces Investigation of Accretive Health, Inc.Business WireWAYNE, Pa.--(BUSINESS WIRE)--Goldman Scarlato Karon & Penny, P.C. (“GSKP”) is investigating potential claims against Accretive Health, Inc. (NYSE: AH) (“Accretive Health” or the “Company”) to determine whether Accretive Health violated the federal securities laws by misrepresenting the sustainability of its business practices and its compliance with federal health privacy laws, state debt collecti ...
- 14y agoAHAccretive Health Initiates Panel of Health Care Policy Experts to Establish National Standards for Health Care Providers’ Financial Interactions with PatientsBusiness WireCHICAGO--(BUSINESS WIRE)--Accretive Health, Inc. (NYSE: AH) announced today that prominent health care and policy leaders have agreed to convene to develop a process for implementing national standards for how hospitals and other providers interact with patients regarding their financial obligations.
- 14y agoAHAccretive Health Reports First Quarter 2012 Financial ResultsBusiness WireCHICAGO--(BUSINESS WIRE)--Accretive Health, Inc. (NYSE: AH), today reported financial results for the first quarter ended March 31, 2012.
- 14y agoAHRobbins Umeda LLP Announces an Investigation of Accretive Health, Inc.Business WireSAN DIEGO--(BUSINESS WIRE)--Shareholder rights firm Robbins Umeda LLP is investigating possible breaches of fiduciary duty and other violations of the law by certain officers and directors at Accretive Health, Inc. (NYSE: AH). Concerned shareholders who would like more information about their rights and potential remedies can contact attorney Gregory E. Del Gaizo at (800) 350-6003, info@robbinsume ...
- 14y agoAHAccretive Health Files Motion to Dismiss Minnesota Attorney General LawsuitBusiness WireCHICAGO--(BUSINESS WIRE)--Accretive Health, Inc. (NYSE:AH) today filed a motion to dismiss the Minnesota Attorney General’s Complaint in federal district court in Minnesota. The motion denies the Attorney General’s claims and requests that the Court dismiss the complaint, in its entirety, with prejudice. As stated in the motion, the Company believes “…the Attorney General’s First Amended Complaint ...
- 14y agoAHStatement from Accretive HealthBusiness WireCHICAGO--(BUSINESS WIRE)--The following statement was issued today by Accretive Health, Inc.:
- 14y agoAHAccretive Health Announces Termination of its Quality and Total Cost of Care Services Contract by Fairview Health ServicesBusiness WireCHICAGO--(BUSINESS WIRE)--Accretive Health, Inc. (NYSE: AH) said today that it has received notice of termination from Fairview Health Services of its Quality and Total Cost of Care (“QTCC”) services contract. The terms of the transition have yet to be determined. The Company will update its business outlook on its quarterly earnings call on May 9, 2012.
- 14y agoAHAccretive Health to Present at the Baird 2012 Growth Stock ConferenceBusiness WireCHICAGO--(BUSINESS WIRE)--Accretive Health, Inc. (NYSE: AH) announced today that it will participate in the Baird 2012 Growth Stock Conference. Mary Tolan, Founder and Chief Executive Officer, and John Staton, Chief Financial Officer, will discuss the company's operations and business outlook starting at 8:55 a.m. CDT on May 10, 2012 at the Four Seasons Hotel in Chicago. A live audio webcast and r ...
- 14y agoAHGlancy Binkow & Goldberg LLP Announces Investigation of Accretive Health, Inc.Business WireLOS ANGELES--(BUSINESS WIRE)--Glancy Binkow & Goldberg LLP announces that it is investigating potential claims on behalf of purchasers of the securities of Accretive Health, Inc. (Accretive Health” or the “Company”) (NYSE:AH) concerning possible violations of federal securities laws. The investigation focuses on allegations that certain statements issued by Accretive Health regarding the Company’s ...
- 14y agoAHCatholic Health East and Accretive Health Announce a Strategic Partnership to Drive Revenue Cycle Standardization and Improved Revenue Cycle YieldBusiness WireNEWTOWN SQUARE, Pa. & CHICAGO--(BUSINESS WIRE)--Catholic Health East and Accretive Health (NYSE: AH) today announced that Accretive Health has been chosen by Catholic Health East to be the health system’s revenue cycle operating partner. Accretive Health will work with Catholic Health East to enable the system to achieve greater standardization of its revenue cycle work processes, generate improve ...
- 14y agoAHAccretive Health to Host First Quarter 2012 Earnings Conference Call on May 9Business WireCHICAGO--(BUSINESS WIRE)--Accretive Health, Inc. (NYSE: AH) will host a conference call on Wednesday, May 9, 2012 at 7:30 a.m. CDT (8:30 a.m. EDT) to discuss its first quarter 2012 financial results and business outlook for fiscal year 2012. A news release containing these results will be issued before the call.
- 14y agoAHAccretive Health Reports Fourth Quarter and Full Year 2011 Results, Provides 2012 GuidanceBusiness WireCHICAGO--(BUSINESS WIRE)--Accretive Health, Inc. (NYSE:AH) today reported strong financial results for the fourth quarter and year ended December 31, 2011, with record net services revenue, adjusted EBITDA, adjusted earnings per share and projected contracted annual revenue run rate (PCARR).
- 14y agoAHWalter H. Ettinger Jr., M.D., Joins Accretive Health as Senior Vice President of Quality and Total Cost of CareBusiness WireCHICAGO--(BUSINESS WIRE)--Accretive Health, Inc. (NYSE: AH) announced today that Dr. Walter Ettinger Jr. has joined the company as Senior Vice President of Quality and Total Cost of Care. Accretive Health partners with health systems across the nation to help providers more efficiently manage their revenue cycle operations, improve their quality of care and reduce overall health care costs. In thi ...